Literature DB >> 33397496

The critical need to develop tools assessing cerebellar reserve for the delivery and assessment of non-invasive cerebellar stimulation.

Mario Manto1,2, Shinji Kakei3, Hiroshi Mitoma4.   

Abstract

Non-invasive cerebellar stimulation (NICS) aims to modulate cerebello-cerebral loops and cerebro-spinal loops, both for research and clinical applications. It is of paramount importance to establish and validate morphological and functional tools to quantify cerebellar reserve, defined as the capacity for restoration and compensation to pathology of the cerebellum. Using NICS without efforts to estimate cerebellar reserve will end up in conflicting results due to the very high heterogeneity of cerebellar disorders encountered in daily practice.

Entities:  

Keywords:  Atrophy; Cerebellum; Non invasive stimulation; Reserve; TMS; tDCS

Year:  2021        PMID: 33397496     DOI: 10.1186/s40673-020-00126-w

Source DB:  PubMed          Journal:  Cerebellum Ataxias        ISSN: 2053-8871


  4 in total

1.  Cerebellar Transcranial Direct Current Stimulation Reconfigures Brain Networks Involved in Motor Execution and Mental Imagery.

Authors:  F Grami; G de Marco; F Bodranghien; M Manto; C Habas
Journal:  Cerebellum       Date:  2021-08-28       Impact factor: 3.648

2.  Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia Type 3: a Randomized, Double-Blind, Sham-Controlled Trial.

Authors:  Roderick P P W M Maas; Steven Teerenstra; Ivan Toni; Thomas Klockgether; Dennis J L G Schutter; Bart P C van de Warrenburg
Journal:  Neurotherapeutics       Date:  2022-05-02       Impact factor: 6.088

Review 3.  Physiology of Cerebellar Reserve: Redundancy and Plasticity of a Modular Machine.

Authors:  Hiroshi Mitoma; Shinji Kakei; Kazuhiko Yamaguchi; Mario Manto
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

4.  Development of Cerebellar Reserve.

Authors:  Hiroshi Mitoma; Shinji Kakei; Mario Manto
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.